Marshall Wace’s EyePoint Inc EYPT Stock Holding History

Marshall Wace’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Sell	23,934 -137,850	-85%	-$1.84M	﹤0.01%	2662
2026 Q1	$2.09M	Buy	+161,784	New	+$2.42M	﹤0.01%	1757
2024 Q2	–	Sell	-388,955	Closed	-$8.04M	–	2663
2024 Q1	$8.04M	Buy	+388,955	New	+$9.63M	0.01%	823
2023 Q3	–	Sell	-89,115	Closed	-$775K	–	2336
2023 Q2	$775K	Buy	89,115 +41,291	+86%	+$252K	﹤0.01%	1829
2023 Q1	$141K	Buy	47,824 +29,353	+159%	+$105K	﹤0.01%	2454
2022 Q4	$64.6K	Buy	+18,471	New	+$81.5K	﹤0.01%	2828
2022 Q1	–	Sell	-11,608	Closed	-$142K	–	3530
2021 Q4	$142K	Buy	+11,608	New	+$156K	﹤0.01%	3279
2021 Q3	–	Sell	-37,746	Closed	-$340K	–	3136
2021 Q2	$340K	Sell	37,746 -69,201	-65%	-$664K	﹤0.01%	2281
2021 Q1	$1.09M	Buy	+106,947	New	+$1.2M	0.01%	1617

Other funds holding EYPT

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Marshall Wace's EYPT Position: Q2 2026 in Review

Marshall Wace reduced its EyePoint Inc (EYPT) stake by 85% in Q2 2026, selling an estimated $1.84M and leaving 23,934 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

Marshall Wace first reported a position in EYPT in Q1 2021 and has held it in 9 quarters since. The position peaked at $8.04M in Q1 2024. 188 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

Marshall Wace held 23,934 shares of EyePoint Inc worth $342K as of Q2 2026.
Marshall Wace sold 137,850 EyePoint Inc shares in Q2 2026, an estimated $1.84M.
EyePoint Inc made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2662 holding.
Marshall Wace first reported a position in EyePoint Inc in Q1 2021 and has held it in 9 quarters since.
Marshall Wace's EyePoint Inc position peaked at $8.04M in Q1 2024.
188 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.